Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir
about
The cost effectiveness of pandemic influenza interventions: a pandemic severity based analysisClinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults.The 2008-2009 H1N1 influenza virus exhibits reduced susceptibility to antibody inhibition: Implications for the prevalence of oseltamivir resistant variant viruses.Clinical characteristics of 2009 pandemic influenza A (H1N1) infection in children and the performance of rapid antigen test.Pandemic influenza A (H1N1) 2009: risk factors for hospitalization.Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categoriesHigh levels and safety of oseltamivir carboxylate plasma concentrations after nasogastric administration in critically ill children in a pediatric intensive care unit.Dried blood spot UHPLC-MS/MS analysis of oseltamivir and oseltamivircarboxylate--a validated assay for the clinic.Simple and sensitive assay for quantification of oseltamivir and its active metabolite oseltamivir carboxylate in human plasma using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry: improved appliThe pharmaceuticalisation of security: Molecular biomedicine, antiviral stockpiles, and global health security.Threats posed by stockpiles of expired pharmaceuticals in low- and middle-income countries: a Ugandan perspective.Zwitterionic structures: from physicochemical properties toward computer-aided drug designs.
P2860
Q28486094-328C74F0-6925-423F-B8E6-A515C7A9DE7DQ30398779-6FED3A52-9032-4675-A7ED-A660052A83DAQ30410229-C05B48E6-2367-4465-9F88-C0FD81E3FCACQ30411554-1020475C-5137-49F5-984C-6D0451FFF8AFQ30414140-080602A9-8052-4DE6-9AE0-F6C4464E5C6FQ30419391-C50A8D0C-159B-4552-AB33-07B38A19D133Q30428319-02A9C731-5F1E-4A31-8D85-8042CF7A56D4Q34483638-FCFE8E67-65BD-4D14-8004-2E4566500FCEQ35059104-6297E5DE-59F4-40F5-8560-1DACC489C5B4Q36395220-8F2A89D4-AD7C-4733-942B-963297835366Q37172892-A6E813D4-D286-4E06-BFA3-ACB89DF904ADQ38368909-95F96380-6139-4128-8EC5-214D0D6F8C5CQ38792090-322986AD-ED0D-4DFA-A47D-EF69595023C7
P2860
Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir
@ast
Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir
@en
type
label
Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir
@ast
Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir
@en
prefLabel
Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir
@ast
Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir
@en
P2860
P921
P356
P1476
Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir
@en
P2093
David Reddy
P2860
P304
P356
10.1093/JAC/DKQ014
P407
P478
65 Suppl 2
P5008
P577
2010-04-01T00:00:00Z